Stroke — Perception of Electrical Stimuli in Individuals With Stroke
Citation(s)
Chapman, C E., Zompa, I. C., Williams, S. R., Shenasa, J. & Jiang, W. Factors influencing the perception of tactile stimuli during movement. in Somesthesis and the Neurobiology of the Somatosensory Cortex (eds. Franzén, O., Johansson, R. & Terenius, L.) 307-320 (Birkhäuser Basel, 1996).
Jacobs BL, Martin-Cora FJ, Fornal CA Activity of medullary serotonergic neurons in freely moving animals. Brain Res Brain Res Rev. 2002 Oct;40(1-3):45-52. doi: 10.1016/s0165-0173(02)00187-x.
Pavlenko, V B. Self-initiated motor behavioral act-related neuronal activity in the cat Locus Coeruleus. Neurophysiology 35, 29-37 (2003).
Post LJ, Zompa IC, Chapman CE Perception of vibrotactile stimuli during motor activity in human subjects. Exp Brain Res. 1994;100(1):107-20. doi: 10.1007/BF00227283.
Seki K, Fetz EE Gating of sensory input at spinal and cortical levels during preparation and execution of voluntary movement. J Neurosci. 2012 Jan 18;32(3):890-902. doi: 10.1523/JNEUROSCI.4958-11.2012.
Seki K, Perlmutter SI, Fetz EE Sensory input to primate spinal cord is presynaptically inhibited during voluntary movement. Nat Neurosci. 2003 Dec;6(12):1309-16. doi: 10.1038/nn1154. Epub 2003 Nov 16.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
